Feasibility and safety of a multi-cancer blood test for screening and intervention
We evaluated the feasibility and safety of blood testing for cancer in an interventional study of 10,006 women. Positive tests for DNA or protein were independently confirmed and diagnostic PET-CT imaging was used to localize disease. During the study, 26 cancers were first detected by blood testing, 24 more by standard-of-care screening, and 46 by neither approach. Surgicalexcision of the primary tumors was performed on 12 cancers first detected by blood testing.1.0% of participants underwent PET-CT imaging based on false positive blood tests, and 0.22% underwent a futile invasive diagnostic procedure. These data demonstrate that multi-cancer blood testing, when followed by PET-CT localization, can be safely incorporated into routineclinical care, in some cases leading to surgery with intent to cure. Further studies will be required to determine the clinical validity and utility of multi-cancer blood testing.
- Type: Other
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001008415 | Illumina HiSeq 4000 Illumina MiSeq | 4127 | |
| EGAD00001008591 | Illumina HiSeq 4000 | 81 | |
| EGAD00001008597 | Illumina HiSeq 4000 Illumina MiSeq | 5111 | |
| EGAD00001015360 | Illumina HiSeq 4000 Illumina MiSeq | 1 | |
| EGAD00001015426 | Illumina HiSeq 4000 Illumina MiSeq | 1 | |
| EGAD00001015458 | Illumina HiSeq 4000 | 1 | |
| EGAD50000000444 | 9911 |
| Publications | Citations |
|---|---|
|
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.
Science 369: 2020 eabb9601 |
420 |
